HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bucked Up Bucks Brand Sponsorship Trends: Rodeo Champions, Bare Knuckle Fighting, Ball Hockey

Executive Summary

Firm also recently became official energy drink partner of Bare Knuckle Fighting Championship and an official sponsor of National Ball Hockey League for 2023 season and of Jimmy Johnson’s “Quest for the Ring” Championship Fishweek in Florida.

You may also be interested in...



Health And Wellness Launches: C4, CV Sciences, pH-D Feminine, Bucked Up, VitaStix, Shifted

C4 Relaunch “highlights people getting unstuck”; pH-D line extends with menopause, menstrual and heart supplements; CV Sciences doubles THC in +PlusCBD Reserve Collection Extra; VivaStix Instant Energy + Electrolytes; Bucked Up Pixie Pump pre-workout.

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

NMN Supplement Firm Works On Disclosing Sales Relationships With Advertising Affiliates

Renue By Science agrees with National Advertising Division recommendations to “clearly and conspicuously disclose” material connections in online advertising by employees, nonprofits and others offering sales to its supplements containing nicotinamide mononucleotide, quercetin or resveratrol.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153682

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel